BioHouston RSS Feed

2012 ABFO National Conference on 29-May-12 7:00 AM

Tue, 29 May 2012 12:00:00 GMT

2012 ABFO National Conference
Start Date: 29-May-12 7:00 AM
End Time: 1-Jun-12 5:30 PM
Location: The Westin Copley Plaza, Boston, MA
Event Details:

Registration for the 23rd Annual ABFO conference in Boston is open! Your Conference Committee is pleased to announce that we have put together an exceptional panel of experts for our Friday morning session on "Innovation." Louise Mawhinney, Sr. Vice President, and CFO of Ikonisys, Inc. will moderate:

Patrice Milos, PhD, Site Head, Boston Pfizer Center for Therapeutic Innovation

Abbie Celniker, PhD, CEO, Eleven Biotherapeutics, Inc.,

Daphne Zohar, Founder and Managing Partner, PureTech Ventures

Lydia Villa-Komaroff, PhD, Chief Scientific Officer, Boad Member, Cytonome/SF, LLC

This panel will address the future of the innovation ecosystem and pose fundamental questions such as, “Who will fund the innovations of tomorrow?” and “Where does innovation come from, and who gets rewarded?” The concept of pre-competitive research and development is very important for moving innovation forward, but how comfortable is pharma with today’s models for collaboration, and at what level?

It’s all at the conference… great people, new ideas and exceptional experiences. We look forward to welcoming you to Historic Boston May 29th to June 1st at The Westin Copley Place. You’ll want to register early for this exciting event, which draws Financial Executives from around North America. So don’t hesitate, visit the Conference website http://www.abfointernational.org/conference.html for session details and to register online today!

See you in Boston!

Harry Trout III
ABFO Conference Chair
ENANTA Pharmaceuticals, Inc.

To view this html email as a webpage in your browser, please use this LINK

You are receiving this invitation because you have indicated interest in ABFO, are an ABFO Member Representative,
or come to one of our meetings.
If you have questions or comments or wish to be removed from our distribution list,
please contact the ABFO Membership Coordinator, Genie Hawkins at abfogenie@comcast.net

The Westin Copley Plaza

2012 IEDC Annual Conference on 30-Sep-12 8:30 AM

Sun, 30 Sep 2012 13:30:00 GMT

2012 IEDC Annual Conference
Start Date: 30-Sep-12 8:30 AM
End Time: 3-Oct-12 5:30 PM
Location: Hilton Americas - Houston, Houston, TX 77010
Event Details:

Join IEDC in Houston, Texas September 30 - October 3, 2012, for the world's largest annual gathering of economic developers as industry leaders break down the current issues and new models essential for anyone looking to adapt and rejuvenate their community. You will be able to:

EXCHANGE information and build relationships with experts in economic development, chambers of commerce, consultants, workforce development and more!
LEARN from industry experts as they discuss models that can be replicated in your community.
EXPERIENCE Houston and its surrounding communities through tours and case studies

Hilton Americas - Houston

1600 Lamar

Houston, TX US 77010

Individual Sponsor on 11-Sep-48 11:30 AM

Fri, 11 Sep 2048 16:30:00 GMT

Individual Sponsor
Start Date: 11-Sep-48 11:30 AM
End Time: 11-Sep-48 1:30 PM
Location: Crystal Ballroom at the Rice Hotel, Houston, TX 77002
Event Details:

2008 Annual Luncheon

Bringing Research to Life

Dr. Elsa Murano

Texas A&M University

September 11, 2008

11:30 AM - 1:30 PM

The Crystal Ballroom at The Rice

909 Texas Ave.

Houston, TX 77002

The upcoming BioHouston annual luncheon, Bringing Research to Life, will feature the new Texas A&M President, Dr. Elsa Murano, as our speaker. Research, particularly in the rapidly expanding life sciences, is the cornerstone in Texas A&M’s quest to become a top-10 public institution by 2020. The impact of this aggressive initiative by the Aggies is far-reaching, as well as critical in expanding the intellectual capital of the state.

Dr. Murano began her professorial career in 1990 as an Assistant Professor in the Department of Microbiology, Immunology and Preventative Medicine at Iowa State, the position she held prior to joining the Texas A&M faculty. She received a bachelor's degree in biological sciences from Florida International University, and earned both a master's degree in anaerobic microbiology and a doctorate in food science and technology from Virginia Tech. Dr. Murano is the first woman and first Hispanic-American to lead the oldest public institution of higher learning in Texas—now one of the largest teaching and research universities in the nation.

Proceeds from the luncheon will benefit BioHouston’s initiatives to build the region’s biotech industry, creating medical breakthroughs that will transform health care, improve lives, and create economic growth.

For questions regarding sponsorship or event information, contact Keisha Curtis at 713-979-9212 or keisha.curtis@biohouston.org

Crystal Ballroom at the Rice Hotel

909 Texas Ave.

Houston, TX US 77002

BioHouston Newsletter 5-Jul-11

Lacey Webster - noemail@biohouston.org — Tue, 05 Jul 2011 21:39:18 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Calendar Events
Releases
Job Listings

Calendar Events for 5-Jul-11 to 1-Oct-11

Summer 2011 Course for Professionals
Speaker's Name:
Day: Monday 8-Aug-11 9:00 AM to Friday 12-Aug-11 5:00 PM
Location:
Summary: A one week bioprocessing training course to familiarize individuals with the process behind biomanufactured goods and therapeutics. Trainees will receive hands on time with a biofermentor to grow a geneti...
Add to Calendar
Posted by: Lacey Webster

Rice University Short Course: Advances In Tissue Engineering
Speaker's Name:
Day: Wednesday 10-Aug-11 8:00 AM to Saturday 13-Aug-11 5:30 PM
Location: Rice University Houston, TX
Summary: COURSE FEATURES The latest on patient-specific therapeutics featuring speakers from academia, medical research, and industry....
Add to Calendar
Posted by: Lacey Webster

BioPharm America 2011: 4th Annual International Partnering Conference
Speaker's Name:
Day: Wednesday 7-Sep-11 8:30 AM to Friday 9-Sep-11 5:30 PM
Location: Westin Boston Waterfront Hotel 425 Summer Street Boston, MA 02210
Summary: BioPharm America™ is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped...
Mapquest | Add to Calendar
Posted by: Lacey Webster

Annual Luncheon Celebrating Women in Science
Speaker's Name:
Day: Tuesday 20-Sep-11 11:30 AM to 1:00 PM
Location: Rice Hotel, downtown Houston
Summary: By celebrating the achievements of women leaders in science, BioHouston's goal is to inspire others to pursue research and applications that will spur economic growth and prosperity for our region and our state as a whole. ...
Add to Calendar
Posted by: Lacey Webster

Releases for 5-Jun-11 to 5-Jul-11

Baylor College of Medicine and Texas Children's Hospital Neuroscientist Dr. Huda Zoghbi Awarded Gruber Neuroscience Prize

Author:

Release Date: Wednesday 15-Jun-11 8:00 AM

Receives $500,000 Gruber Neuroscience Prize for pioneering work in revealing the genetic and molecular underpinnings of neurological... [More Info]
Posted by: Lacey Webster

Mystic Pharmaceuticals Receives U.S. Patent for Novel Packaging Technology for Drugs and Biologics

Author:

Release Date: Monday 13-Jun-11 11:00 AM

AUSTIN, TX - June 13, 2011 (Business Wire) -- Mystic Pharmaceuticals, Inc. announces today that it has been granted U.S. Patent... [More Info]
Posted by: Lacey Webster

June 9, 2011 - Enabling microRNA Discoveries - 250th peer-reviewed publication made possible by µParaflo® custom microarray technology

Author:

Release Date: Thursday 9-Jun-11 12:00 PM

Houston, TX - LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery... [More Info]
Posted by: Lacey Webster

Study Validates Clinical Accuracy of 50% Dose Reduction for Positron Emission Mammography

Author:

Release Date: Tuesday 7-Jun-11 4:00 PM

PR Newswire SAN ANTONIO, June 7, 2011 SAN ANTONIO, June 7, 2011 /PRNewswire/ -- Presented today at the Society of... [More Info]
Posted by: Lacey Webster

Apollo Endosurgery Taps Michael Doty for CFO

Author:

Release Date: Tuesday 7-Jun-11 8:00 AM

AUSTIN, Texas, June 7, 2011 /PRNewswire/ -- Apollo Endosurgery, Inc., a leading company in the emerging field of flexible surgery,... [More Info]
Posted by: Lacey Webster

Azaya Therapeutics Presents Phase I Data at ASCO and Completes Offering

Author: Lacey Webster

Release Date: Monday 6-Jun-11 11:00 AM

Phase I study conducted at two premier cancer research facilities in Texas $3.5 million convertible debt offering... [More Info]
Posted by: Lacey Webster

Jobs for 5-Jun-11 to 5-Jul-11

Sr. Technology Licensing Associate

Company: The University of Texas Health Science Center at Houston

Date Activated: Tuesday 21-Jun-11 0:00 AM

The University of Texas Health Science Center at Houston (UTHealth) has an immediate opening for the position of Senior Technology... [More Info]
Posted by: Christine Flynn

Director of Quality and Regulatory

Company: Apollo Endosurgery

Date Activated: Thursday 16-Jun-11 12:46 PM

POSITON SUMMARY Reporting directly into the CEO, the Director of Quality and Regulatory will oversee and manage Apollo... [More Info]
Posted by: Lacey Webster

Stay up to date with our RSS feeds.

5-Jul-11 4:39 PM

Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney

Wed, 14 Oct 2009 19:00:00 GMT

Investing in biotech can be scary. Only one out of 10 new drug candidates ever makes it through the gauntlet of clinical trials to become an FDA approved product, and it usually takes hundreds of millions of dollars and a decade or more of research to separate the winners from the losers. Investors usually can’t bother asking serious questions about profit-and-loss statements, or price-to-earnings ratios, until a company is 15 years old or more. And the hype—from gene therapy, to stem cells, to you fill in the blank—can be quite distracting.

So Christopher Henney, 68, who has seen it all in a 30-year career in biotech as co-founder of Immunex, Icos, and Dendreon, knew he had his work cut out yesterday. He was trying to convince a crowd of 100 financial pros at the CFA Society meeting in Seattle that biotech, the classic boom-or-bust industry, is really a good place to invest.

“I want to de-mythologize the scariness,” Henney said at the outset.

Henney started off his talk by reminding the audience how he and Steve Gillis, a pair of immunologists at the Fred Hutchinson Cancer Research Center, went on to start Seattle-based Immunex, one of the members of what he called “the class of 1983.” These were the second-generation companies, following industry pioneer Genentech, that all went public back in a great wave of enthusiasm for biotechnology. The class included Amgen, Biogen, Cetus, Chiron, Genzyme, and Immunex. Seven of the 10 to 12 biotech companies (Henney didn’t name the losers) that went public in that early wave went on to create market valuations that exceeded $1 billion, Henney said.

But even during that great wave of optimism about the power of new genetic engineering technologies for creating new drugs, there were prominent skeptics. Henney told the story of how he and Gillis had a meeting in the early days of Immunex with “one of the doyennes” of the Seattle investment community, whom he didn’t name. Henney and Gillis told their story with great enthusiasm, and got a rude awakening.

“At the end, I remember him saying, ‘I don’t think it’s a scam, but I won’t introduce you to anybody, either,’” Henney recalled.

Both of them were academic scientists who “had a fair amount of hubris about our self-worth. To be told that what we’re doing was a scam, it wasn’t something I wanted to tell my Mom about,” Henney said.

He added, “It was our welcome-to-the-NFL moment.”

Still, the investor taking that position would have been right for the first 15 years or so. It took 17 years from Immunex’s founding before it struck gold with etanercept (Enbrel), a drug for autoimmune diseases that now generates more than $7 billion a year in worldwide sales for Amgen and Wyeth. It took much longer, and hundreds of millions of dollars more than industry pioneers like Henney thought it would, to create blockbuster drugs like that. “If you had thought about that beforehand, nobody would have given us any money at all,” Henney said.

But they got the money, and learned a lot of lessons along the way. In his talk last week, Henney distilled them into six hallmarks of a successful biotech that investors should look for, along with five red flags to watch out for as well (which I’m going to save for another story).

So, here are the six hallmarks to look for in a successful biotech company, according to Henney:

—Solid Patents. All good biotech companies must have terrific science, and they must have patents to protect it, Henney says. In the industry’s early days, there weren’t many patent attorneys that knew what they were doing, but now there are plenty, he says. An investor ought to ask “how does the science stack up” at a company versus its competitors.

—The science should be focused on an important disease, with potential for breakthroughs. Lots of scientists will argue about what’s important and what’s not, but what an investor needs to know is that a biotech company is at the front of the pack. Immunex focused on an important disease, rheumatoid arthritis, and clearly made a breakthough. “You don’t want to be in fourth or fifth place” with a new drug, he says.

—Great management. This is a must in all industries, but it can’t be overstated in biotech. Interestingly, Henney has noticed some unusual character traits about biotech managers that he says shouldn’t scare off investors. “Like you see in software, these are managers who don’t walk into a room and dominate it. They are often fairly nerdy. But we’re talking about people who are smart, efficient managers,” Henney said.

—Access to capital. A company has to be able to prove it can raise money. Again, and again, and again. “Not many biotech companies go out of business because they lack ideas,” Henney said.

—Luck. “You need it. I’m fortunate to say Lady Luck visited me on many occasions,” Henney said. (I’m not sure how investors are supposed to be able to gauge whether a company has luck on its side, though.)

—Flexible attitudes toward human resources. This might sound nutty to straight-laced business school types, but biotech companies need to give breathing room to some brilliant, creative people who aren’t closely directed by management, Henney said. This can work for a small percentage of the top performers, like some of the brightest people at the National Institutes of Health. The most famous case of this in biotech, which Henney didn’t mention, came from Genentech scientist Napoleone Ferrara, who made discoveries in 1989 on his undirected time that gave birth to the breakthrough cancer drug bevacizumab (Avastin).

“You’ve got to let people follow their curiosity,” Henney said. “For some in the business community, that might sound like a sketchy proposition, but you have to.”

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman

14-Oct-09 2:00 PM

MedSource Honored at Houston Fast 100 Event; Ranked No. 11 on List of Fastest Growing Companies

Mon, 21 Sep 2009 20:00:00 GMT

Houston, September 22, 2009 – Houston’s 100 fastest-growing companies and 2009 Power Five were honored at the Houston Fast 100 luncheon presented by the Houston Business Journal and held at the InterContinental Houston Hotel. MedSource, a Contract Research Organization (CRO) specializing in complex clinical trials, was ranked as No. 11 on the Houston Fast 100 list.

Over 700 Houstonians from the business community cheered on the 2009 Fast 100 award recipients at the luncheon on September 11, 2009, where the rankings were first made public. Companies making the list were ranked by percentage of revenue growth over the past two years. MedSource, with a rapid growth rate of more than 213 percent over the past two years, also earned a place on the 2009 Inc. 5000 List.

“We appreciate recognition from the Houston Business Journal and are proud to be a part of Houston’s thriving business community. There is an active biotech community here in Houston, and it is part of our mission to support the goals of that community. MedSource has been able to find traction in this current economy by focusing on quality, service, and integrity. It is what we have built our reputation on and it is how we will continue to do business,” said Eric Lund, president of MedSource.

In addition to the list of Houston’s 100 fastest-growing companies published in the special Houston Fast 100 section of the Houston Business Journal’s September 11, 2009 issue, top executives of some of the honored businesses shared their insights on what to do and what not to do to succeed.

The Houston Fast 100 event was hosted by the Houston Business Journal and presented by Whitney Bank. Co-sponsors of the event were G&A Partners, Pierpont Communications, Reliant Energy, Staples, and Verizon Wireless.

About MedSource

MedSource is a premier Contract Research Organization (CRO) based in Houston, TX dedicated to delivering on-time, reliable clinical trial management services. MedSource has been providing quality results in Phase I-IV studies since 2001 and has extensive experience in complex clinical trials, with a particular expertise on oncology related programs. They have quickly grown into one of the premier CROs in North America and have been recognized as an Inc. 500/5000 company a Houston Fast 100 company. With clinical trial monitors located throughout North America and active vendor relationships globally, MedSource is able to quickly and effectively meet the clinical trial needs of their clients. More information about MedSource can be found at www.medsource.com or by calling (281) 286-2003.

Company contact:

Chris Kohnhorst
(281) 203-7707
ckohnhorst@medsource.com

21-Sep-09 3:00 PM

BioHouston Newsletter 21-May-09

Sara Mathews - noemail@biohouston.org — Thu, 21 May 2009 21:00:00 GMT

<img alt="" src="/attachments/wysiwyg/6638/header.jpg" border="0" height="108" width="795">ntitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

Homeland Security Conference
Day: Wednesday 27-May-09 9:00 AM
Location: InterContinental Hotel, 2222 W. Loop South, Houston, TX 77027
Add to Calendar

CEO Dinner
Day: Thursday 4-Jun-09 5:30 PM
Location: Strip House 1200 McKinney Street Houston, TX 77010
Register Mapquest | Add to Calendar

Breakfast Forum-- Update on State of Texas Bioscience Initiative
Day: Wednesday 10-Jun-09 7:30 AM

Location: M. D. Anderson South Campus Research Building II, 7435 Fannin Street, Houston TX 77054

Rice Alliance for Technology and Entrepreneurship Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Associate Advisory Board
Day: Wednesday 17-Jun-09 11:30 AM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Register Mapquest | Add to Calendar

A Moderated Discussion with Serial Entrepreneur Dale Pfost
Day: Thursday 18-Jun-09 4:00 PM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Register Mapquest | Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009
Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

BioHouston Annual Luncheon
Day: Friday 11-Sep-09 11:00 AM
Location:
Add to Calendar

The Fall 2009 Engineering Career Fair
Day: Thursday 17-Sep-09 9:00 AM
Location: University of Houston Hilton Hotel 4800 Calhoun Rd Houston, TX 77004
Mapquest | Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference
Day: Wednesday 11-Nov-09 to 13-Nov-09
Location: Houston, TX
Add to Calendar

News

VGXI, Inc. Presents at the ASGT 12th Annual Meeting in San Diego, CA May 27-31

VGXI Inc. Presents Issues Related to High Concentration, Multi-Component Plasmid Products at the American Society of Gene Therapy 12th... [More Info]

FDA clears new KCI abdominal wound-care product

Kinetic Concepts Inc. has received Food and Drug Administration approval on its newest product designed to help patients heal from an... [More Info]

Stericycle to buy MedServe for $185 million

Medical waste handling company MedServe Inc. is being acquired by Stericycle Inc. for $185 million in cash. Houston-based MedServe is... [More Info]

MedSource Awarded Services Contract for a Phase III Epilepsy Clinical Trial

(Houston, Texas) – May 12, 2009 - MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced... [More Info]

Blausen Introduces New 3D Animations iPhone App

Normal 0 false false false st1\:*{behavior:url(#ieooui) } /* Style Definitions */ table.MsoNormalTable... [More Info]

Emerging Biotechnology Clusters

Boston, San Francisco, San Diego, and Cambridge are on everyone’s list of the top biotech clusters. Medicon... [More Info]

KCI claims partial victory in patent fight against Smith & Nephew

Kinetic Concepts Inc. (KCI) said Friday that the Patents Court of the High Court of England and Wales has entered a judgment against Smith... [More Info]

Jobs

Human Factors Design Engineer --new

Company: MEI Technologies, Inc.

This position will be within the Anthropometry and Biomechanics Facility (ABF) that is part of the Space Human Factors Laboratory within... [More Info]

Health Outcomes Research Team Leader

Company: Pharm-Olam International Ltd.

Pharm-Olam International ('POI'), a multi-national Contract Research Organization seeks an experienced Health Outcomes Research Team Leader... [More Info]

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Stay up to date with our RSS feeds.

21-May-09 4:00 PM

BioHouston Newsletter 1-May-09

Sara Mathews - noemail@biohouston.org — Fri, 01 May 2009 15:41:06 GMT

tled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

Marketing your Medical Device products to the E.U.
Day: Thursday 14-May-09 11:30 AM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Register Mapquest | Add to Calendar

2009 BIO International Conference

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Location: Atlanta, GA
Add to Calendar

Global Intellectual Property Due Diligence--BIO 2009 Session
Sponsor: Baker & McKenzie
Day: Wednesday 20-May-09 10:00 AM
Location: Georgia World Congress Center (Building B)--B313 Atlanta, GA
Add to Calendar

Healthcare Heroes

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

Location: Wortham Center, Houston, TX
Add to Calendar

Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Rice Alliance for Technology and Entrepreneurship Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009
Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference
Day: Wednesday 11-Nov-09 8:30 AM
Location: Houston, TX
Add to Calendar

News

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused... [More Info]

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III , to Vice... [More Info]

Federal Research Grants Critical to Aiding Economic Recovery, Advancing Medical Innovation, AdvaMed Witness Tells Panel

WASHINGTON , D.C. – Will Rosellini, President and CEO of MicroTransponder Inc., based in Texas, testified on behalf of the Advanced Medical... [More Info]

Biomed company shuttering San Antonio operation

British orthopedic device firm Smith & Nephew confirmed Monday that it is closing down its 30-employee facility in San Antonio by the end... [More Info]

Vidacare adds oncology nurse to management

Vidacare Corp. has hired a nationally recognized oncology nursing specialist to join the company’s management. Kim Brodie joined the... [More Info]

Opexa gets $1 million in financing

Opexa Therapeutics Inc. has secured about $1 million through a private offering of secured convertible notes and warrants. The cell... [More Info]

Glycos Biotechnologies gets $5 million in funding

Glycos Biotechnologies Inc. has received a $5 million infusion led by venture capital firms Draper Fisher Jurveston and DFJ Mercury. The... [More Info]

Jobs

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Stay up to date with our RSS feeds.

1-May-09 10:41 AM

BioHouston Newsletter 1-May-09

Sara Mathews - noemail@biohouston.org — Fri, 01 May 2009 15:28:01 GMT

tled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

News

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused... [More Info]

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III , to Vice... [More Info]

Federal Research Grants Critical to Aiding Economic Recovery, Advancing Medical Innovation, AdvaMed Witness Tells Panel

WASHINGTON , D.C. – Will Rosellini, President and CEO of MicroTransponder Inc., based in Texas, testified on behalf of the Advanced Medical... [More Info]

Biomed company shuttering San Antonio operation

British orthopedic device firm Smith & Nephew confirmed Monday that it is closing down its 30-employee facility in San Antonio by the end... [More Info]

Vidacare adds oncology nurse to management

Vidacare Corp. has hired a nationally recognized oncology nursing specialist to join the company’s management. Kim Brodie joined the... [More Info]

Opexa gets $1 million in financing

Opexa Therapeutics Inc. has secured about $1 million through a private offering of secured convertible notes and warrants. The cell... [More Info]

Glycos Biotechnologies gets $5 million in funding

Glycos Biotechnologies Inc. has received a $5 million infusion led by venture capital firms Draper Fisher Jurveston and DFJ Mercury. The... [More Info]

Jobs

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Stay up to date with our RSS feeds.

1-May-09 10:28 AM

BioHouston Newsletter 30-Apr-09

Sara Mathews - noemail@biohouston.org — Thu, 30 Apr 2009 18:49:30 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

2009 BIO International Conference

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

Location: Wortham Center, Houston, TX

Add to Calendar

Rice Alliance for Technology and Entrepreneurship Life Science Technology Venture Forum

Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009
Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference
Day: Wednesday 11-Nov-09 to Friday 13-Nov-09
Location: Houston, TX
Add to Calendar

News

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

THE WOODLANDS, Texas, April 28 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused... [More Info]

DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance

FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III , to Vice... [More Info]

Federal Research Grants Critical to Aiding Economic Recovery, Advancing Medical Innovation, AdvaMed Witness Tells Panel

WASHINGTON , D.C. – Will Rosellini, President and CEO of MicroTransponder Inc., based in Texas, testified on behalf of the Advanced Medical... [More Info]

Glycos Biotechnologies gets $5 million in funding

Glycos Biotechnologies Inc. has received a $5 million infusion led by venture capital firms Draper Fisher Jurveston and DFJ Mercury. The... [More Info]

Jobs

Senior Support Specialist

Company: The University of Texas Health Science Center at Houston

POSITION SUMMARY: Performs a variety of advanced and complex tasks to support assigned area. Decisions could impact assigned area. ... [More Info]

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Stay up to date with our RSS feeds.

30-Apr-09 1:49 PM

BioHouston Newsletter 16-Apr-09

Tim Graves - noemail@biohouston.org — Thu, 16 Apr 2009 21:34:08 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, articles, jobs and more from our membership.

Events
News
Jobs

Events

ISPE South Central Chapter 10th Annual Educational and Exhibitor Program
Day: Thursday 23-Apr-09 8:30 AM
Location: Crown Plaza 1700 Smith St. Houston, TX 77002
Mapquest | Add to Calendar

2009 BIO International Conference

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 8:30 AM

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM

Location: Wortham Center, Houston, TX
Add to Calendar

Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009

Jetro is interested in helping companies set up an office in Japan....and will pay your booth costs.

Sponsor: JETRO-Houston

Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

BioHouston Annual Luncheon--SAVE THE DATE
Day: Friday 11-Sep-09 11:00 AM
Location: Houston, TX
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference--SAVE THE DATE
Day: Wednesday 11-Nov-09 8:30 AM
Location: Houston, TX
Add to Calendar

News

Funding will help Molecular Templates continue developing cancer treatments

Biopharmaceutical company Molecular Templates Inc. has completed a $2.5 million Series A round of financing. Austin-based Molecular... [More Info]

Life Sciences Center attracts Canadian co. Molecular Templates

The Texas Life-Sciences Collaboration Center attracted its first international tenant — a Canadian-based biotech company called Molecular... [More Info]

SeqWright to Invest in LaserGen's Novel Lightning Terminators(TM)

HOUSTON, April 8 /PRNewswire/ -- LaserGen, Inc., a DNA sequencing technology company, announced a definitive agreement in which SeqWright... [More Info]

OncoVista teams up with CTRC to test newest cancer drug

Two San Antonio cancer organizations are working toward the development on a new drug that could be used as a treatment for solid tumors. ... [More Info]

AirStrip software approved for BlackBerry phones

A day after the Food and Drug Administration approved AirStrip Technologies’ obstetrician application on the Apple iPhone, the company... [More Info]

SeqWright's Clinical Trial Support Contributes to the Approval of Two HPV Diagnostic Systems

HOUSTON, April 7 /PRNewswire/ -- SeqWright Inc., an international leader in the field of contract genomic services, announced today its... [More Info]

ULURU Inc. Signs Offer Letter to Acquire York Pharma plc

ADDISON, Texas, April 6 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) today announced that it has signed a non-binding offer... [More Info]

Jobs

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Health Outcomes Research Team Leader

Company: Pharm-Olam International Ltd.

Pharm-Olam International ('POI'), a multi-national Clinical Contract Research Organization seeks an experienced Health Outcomes Research... [More Info]

Stay up to date with our RSS feeds.

16-Apr-09 4:34 PM

BioHouston Newsletter 16-Apr-09

Tim Graves - noemail@biohouston.org — Thu, 16 Apr 2009 21:01:39 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, news, jobs and more from our membership.

Events
News
Jobs

Events

If your company is traveling to BIO, please let us know. BioHouston has our own booth in Atlanta, and we'd like you to be a part of it!

Day: Monday 18-May-09 to Thursday 21-May-09
Location: Atlanta, GA
Add to Calendar

Global Intellectual Property Due Diligence--BIO 2009 Session
Sponsor: Baker & McKenzie
Day: Wednesday 20-May-09 10:00 AM
Location: Georgia World Congress Center (Building B)--B313 Atlanta, GA
Add to Calendar

Houston Business Journal Healthcare Heroes Awards

Honoring those who serve, innovate and save lives. Do not miss your chance to cheer on the unsung heroes in healthcare. This event is part of Celebrate!Enterprise, a four-day business event.

Day: Wednesday 20-May-09 8:30 AM
Location: Wortham Center, Houston, TX
Add to Calendar

Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

JAIMA SHOW 2009

Jetro is interested in helping companies set up an office in Japan...and will pay your booth costs.

Sponsor: JETRO-Houston
Day: Wednesday 2-Sep-09 8:30 AM
Location: Chiba, Japan
Add to Calendar

BioHouston Annual Luncheon--SAVE THE DATE
Day: Friday 11-Sep-09 11:00 AM
Location: Houston, TX
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

Texas Life Science Conference--SAVE THE DATE
Day: Wednesday 11-Nov-09 8:30 AM
Location: Houston, TX
Add to Calendar

News

Funding will help Molecular Templates continue developing cancer treatments

Biopharmaceutical company Molecular Templates Inc. has completed a $2.5 million Series A round of financing. Austin-based Molecular... [More Info]

Life Sciences Center attracts Canadian co. Molecular Templates

The Texas Life-Sciences Collaboration Center attracted its first international tenant — a Canadian-based biotech company called Molecular... [More Info]

SeqWright to Invest in LaserGen's Novel Lightning Terminators(TM)

HOUSTON, April 8 /PRNewswire/ -- LaserGen, Inc., a DNA sequencing technology company, announced a definitive agreement in which SeqWright... [More Info]

OncoVista teams up with CTRC to test newest cancer drug

Two San Antonio cancer organizations are working toward the development on a new drug that could be used as a treatment for solid tumors. ... [More Info]

AirStrip software approved for BlackBerry phones

A day after the Food and Drug Administration approved AirStrip Technologies’ obstetrician application on the Apple iPhone, the company... [More Info]

SeqWright's Clinical Trial Support Contributes to the Approval of Two HPV Diagnostic Systems

HOUSTON, April 7 /PRNewswire/ -- SeqWright Inc., an international leader in the field of contract genomic services, announced today its... [More Info]

ULURU Inc. Signs Offer Letter to Acquire York Pharma plc

ADDISON, Texas, April 6 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Amex: ULU) today announced that it has signed a non-binding offer... [More Info]

Jobs

Formulation Scientist

Company: Vapogenix, Inc.

Vapogenix Inc is a preclinical drug development company located south of the Texas Medical Center in Houston, TX. The Company is seeking... [More Info]

Health Outcomes Research Team Leader

Company: Pharm-Olam International Ltd.

Pharm-Olam International ('POI'), a multi-national Clinical Contract Research Organization seeks an experienced Health Outcomes Research... [More Info]

Stay up to date with our RSS feeds.

16-Apr-09 4:01 PM

BioHouston Newsletter 2-Apr-09: Chili Cook-off tomorrow

Tim Graves - noemail@biohouston.org — Thu, 02 Apr 2009 17:15:56 GMT

Untitled Document

Hello [firstname],

Welcome to the BioHouston newsletter of upcoming events, news articles, jobs and more from our membership.

Events
News
Jobs

Events

6th Annual Chili Cook-Off
Register at the Door on Friday -- Yes, that's tomorrow!
Day: Friday 3-Apr-09 12:00 PM
Location: BioHouston Offices 2555 Holly Hall St., Ste. 100 Houston, TX 77054
Mapquest | Add to Calendar

Breakfast Forum
David Callender, M.D., President, The University of Texas Medical Branch
Day: Tuesday 14-Apr-09 7:30 AM
Location: M. D. Anderson South Campus Research Building II 7435 Fannin Street Houston, TX 77054
Register Mapquest | Add to Calendar

BioCamp Houston
Day: Saturday 4-Apr-09 9:00 AM
Location: 100 Keck Hall, Rice University Campus 6100 Main St. Houston, TX
Mapquest | Add to Calendar

10th Annual Spring Conference
Day: Thursday 23-Apr-09 8:30 AM
Location: Crown Plaza 1700 Smith St. Houston, TX 77002
Mapquest | Add to Calendar

2009 BIO International Conference
Day: Monday 18-May-09 8:30 AM
Location:
Add to Calendar

Healthcare Heroes Awards
Day: Monday 20-May-09
Add to Calendar

Life Science Technology Venture Forum
Day: Thursday 11-Jun-09 9:00 AM
Location: Rice University, McNair Hall, Jones Graduate School of Management
Add to Calendar

Advances in Tissue Engineering 2009
Day: Wednesday 12-Aug-09 8:30 AM
Location: Duncan Hall at Rice University
Add to Calendar

The UP Experience
Day: Thursday 15-Oct-09 8:30 AM
Location: The Stafford Centre 10505 Cash Road Stafford, TX 77477
Mapquest | Add to Calendar

News

San Antonio firm picked to market health care inventory software

Diversified Hospitals & Healthcare Solutions has agreed to serve as a distributor for health care software company VUEMED. Through this... [More Info]

KCI will eliminate 300 positions worldwide

Kinetic Concepts Inc. said Monday that the company is planning on laying off 4 percent of its work force, or 300 employees, worldwide. San... [More Info]

Dallas entrepreneur's latest device interrupts nerve signals to relieve pain

At 29, Will Rosellini has accomplished more than what it takes most people a lifetime to start. The degrees: masters in... [More Info]

Bill Gimson to head Cancer Prevention and Research Institute of Texas

Bill Gimson will lead the new Cancer Prevention and Research Institute of Texas as its executive director. CPRIT is charged with using $3... [More Info]

OncoVista subsidiary awarded U.S. patent for anti-cancer technology

The U.S. Patent and Trademark Office has issued OncoVista Innovative Therapies Inc. and its AdnaGen AG subsidiary a patent for the... [More Info]

Reata Completes Financing and Expands Team to Capture Opportunity Created by Encouraging Clinical Data in Chronic Kidney Disease

Late Stage Clinical Trial Initiated in Patients with Advanced Chronic Kidney Disease IRVING, TX - March 25, 2009 -- Reata Pharmaceuticals,... [More Info]

KV Pharmaceutical layoffs hit The Woodlands

KV Pharmaceutical Co.’s plan to lay off about 1,700 employees has made its way to the Houston area. The St. Louis-based pharmaceutical... [More Info]

VGX working on malaria vaccine for PATH

VGX Pharmaceuticals reached an agreement with the PATH Malaria Vaccine Initiative Monday to design and test DNA vaccine candidates capable... [More Info]

Jobs

Health Outcomes Research Team Leader --new

Company: Pharm-Olam International Ltd.

Pharm-Olam International ('POI'), a multi-national Clinical Contract Research Organization seeks an experienced Health Outcomes Research... [More Info]

Stay up to date with our RSS feeds.

2-Apr-09 12:15 PM

PLx Pharma gets grant for research into heart med for premature babies

noemail@biohouston.org — Sat, 28 Apr 2012 13:00:00 GMT

HOUSTON - (March 28, 2012) - PLx Pharma Inc, a Houston-based pharmaceutical company developing a medical discovery made at The University of Texas Health Science Center at Houston (UTHealth) Medical School, has been awarded $565,449 for the first year of a potential two-year $1,118,398 grant to conduct research designed to enhance a treatment for premature babies with a common congenital heart defect. Patent ductus arteriosus (PDA) is a leading cause of death in low birth weight premature infants. It can occur when a heart vessel that normally closes on its own after birth remains open. It can affect about half of the very low birth weight infants. The grant is from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. A major breakthrough in the treatment for PDA occurred with the discovery that a non- steroidal anti-inflammatory drug (NSAID) named indomethacin speeds the closure process. It is the standard of care in many hospitals, often...

Opexa to Hold Preliminary Investigator's Meeting for MS Trial at American Academy of Neurology Annual Meeting

noemail@biohouston.org — Thu, 19 Apr 2012 14:00:00 GMT

THE WOODLANDS, Texas--(April 19, 2012)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tovaxin, a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company will be holding a preliminary meeting with prospective clinical trial investigators at the 64th Annual American Academy of Neurology (AAN) Meeting in New Orleans on April 24, 2012. The purpose of this meeting will be to discuss the upcoming Phase IIb clinical trial using Opexa's T-cell therapy in patients with Secondary Progressive Multiple Sclerosis (SPMS). We are honored to introduce our next clinical trial to a group of invited neurologists at this year's AAN meeting in New Orleans commented Neil K. Warma, President and Chief Executive Officer of Opexa. The meeting will be an opportunity to discuss with select clinicians and their study coordinators potential participation in the SPMS clinical trial as well as present the final protocol for the trial including...

Mystic Pharmaceuticals to Present at the International Nasal and Buccal Drug Delivery Conference

noemail@biohouston.org — Wed, 11 Apr 2012 14:00:00 GMT

AUSTIN, TX - 11 April 2012 - Mystic Pharmaceuticals, Inc. announced today that President and CEO Timothy Sullivan will present at the Nasal and Buccal Drug Delivery Conference in London on April 23 - 24, 2012. This annual conference brings together international experts and innovators to present and discuss the latest research, discovery and developments in nasal and buccal delivery of drugs and biologics. Leading researchers from academia and the pharma industry will present the latest advances in drug and vaccine development and delivery technologies. Timothy Sullivan will present on the topic of Novel Advances in Self Administered Intranasal Delivery For Drugs and Biologics on April 24th. Mr. Sullivan's presentation will provide a technical overview of Mystic's VersiDoser and VRx2TM Delivery Platforms and systemic nasal delivery systems for drugs and biologics. The presentation will also address rapid unit dose fill fit finish production and the mission critical role these...

Lee's Pharmaceutical licenses GI safer aspirin product for China from PLx Pharma

noemail@biohouston.org — Tue, 10 Apr 2012 14:00:00 GMT

Houston and Hong Kong, April 10, 2012‐‐ PLx Pharma Inc, a Houston based pharmaceutical company developing gastrointestinal (GI) safer drugs has licensed to Lee's Pharmaceutical Holdings Limited (Lee's Pharma) the rights to register and commercialize in China, Hong Kong and Macau the PL2200 Aspirin, a GI safer aspirin product currently in development in the US, for prevention of cardiovascular diseases. Cardiovascular is one of the focus areas of Lee's Pharma. Currently, Lee's Pharma has 10 products either launched or under development for cardiovascular diseases such as pulmonary arterial hypertension, hypertension, heart failure and acute coronary disease. PLx has a technology that retains aspirin's benefits and at the same time reduces its primary side effect, GI toxicity. This dramatically improves an already well known drug and we want to make it available to a large and growing Chinese population at risk for cardiovascular disease says Benjamin Li, M.D., the...

State Institute Awards More Than $81 Million to Support Cancer Drug Discover and Development in Texas

noemail@biohouston.org — Thu, 29 Mar 2012 13:00:00 GMT

March 29, 2012 -- Austin, Texas -- The Cancer Research and Prevention Institute of Texas (CPRIT) today announced funding in excess of $81 million to support cancer research and commercialization projects in Texas. The 25 newly funded projects bring the total amount of grants by CPRIT since its inception in 2007 to more than $650 million. This latest round of funding includes $20 million for a Houston-area pre-commercialization center to incubate promising oncology-focused technologies, as well as three CPRIT Scholar in Cancer Research awards to attract top investigators in oncology research to Texas. In addition, Cell Medica, a leading company that develops cellular immunotherapies for oncologic applications, will relocate its headquarters from the UK to Texas, bringing with it jobs and plans to establish a manufacturing and distribution facility in the state. CPRIT is proud to fund groundbreaking research that will advance therapeutic and supportive care approaches to cancer...

FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid Syndrome

noemail@biohouston.org — Tue, 20 Mar 2012 13:00:00 GMT

The Woodlands, Texas, March 20, 2012 - Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that the U.S. Food and Drug Administration (FDA) has granted its request for Orphan Drug designation fortelotristat etiprate (LX1032) for the treatment of carcinoid syndrome. Carcinoid syndrome is a chronic condition caused by neuroendocrine tumors that usually originate from the gastrointestinal tract and is characterized by severe diarrhea and flushing episodes with long-term consequences that may include cardiac valve disease. Symptoms of carcinoid syndrome have been linked to excess production of serotonin by metastatic tumor cells. Telotristat etiprate is an orally-delivered serotonin synthesis inhibitor (SSI) drug that acts to reduce serotonin levels. The Orphan Drug designation of telotristat etiprate by the FDA provides important benefits for this drug's clinical development for carcinoid syndrome, commented Dr. Pablo Lapuerta, senior vice...

RadioMedix, Inc. Receives $1.4 Million Second Tranche Investment From Texas Emerging Technology Fund

noemail@biohouston.org — Fri, 16 Mar 2012 14:00:00 GMT

March 5th, 2012 - RadioMedix, Inc. (Houston, TX) announced today that it successfully met its milestone obligations and has received its second $1.4 million tranche funding from the State of Texas Emerging Technology Fund (ETF). RadioMedix is developing new radiopharmaceutical platforms and automated synthesizers to aid the manufacture of radiopharmaceuticals for positron emission tomography (PET) and will use this continued State of Texas funding to commercialize two innovative products that will permit users to generate and 68Ga-label PET radiotracers on-site at a significantly reduced cost. Over the past year RadioMedix has used the first tranche of ETF funding to complete development of the SyntheMedixTM system and to continue pre-clinical development of the GlucoMedixTM PET imaging agent. In June, the company filed a patent on a new series of radiopharmaceutical agents which utilize a proprietary chelation technology that actively targets tumor cell metabolic pathways....

Houston Medical Robotics, Inc. Receives FDA 510(k) Clearance for EuclidTM Tier 1 Mini Access System

noemail@biohouston.org — Mon, 05 Mar 2012 15:00:00 GMT

HOUSTON, March 5, 2012 /PRNewswire/ -- Houston Medical Robotics, Inc. announces that it has received U.S. Food and Drug Administration 510(k) clearance to market the EuclidTM Tier 1 Mini Access System. The EuclidTM Tier 1 Mini Access System is a portable, hand-held device that integrates commercially available ultrasound imaging systems to facilitate placement of a needle and guidewire into a targeted anatomical location for a variety of therapeutics applications. Although numerous applications have been identified, our initial target for the EuclidTM Tier 1 Mini Access System is reducing complications associated with central venous catheter (CVC) placement, stated Jeffery J. Sheldon, Houston Medical Robotics, Inc. Chairman & CEO. With over 5 million CVCs placed each year - and published complication rates are as high as 26% - we are poised to make a significant impact on healthcare outcomes, stated Mr. Sheldon. Technology limitations, inadequate procedure training & exposure,...

Opexa Therapeutics Executes Strategic Service Agreement with Pharmaceutical Research Associates to Manage Clinical Trial

noemail@biohouston.org — Wed, 29 Feb 2012 15:00:00 GMT

THE WOODLANDS, Texas--(February 29, 2012)--Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tovaxin, a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has executed an agreement with Pharmaceutical Research Associates, Inc. (PRA) to provide contract research organization (CRO) services to support Opexa's upcoming Phase IIb clinical trial for Tovaxin in patients with Secondary Progressive multiple sclerosis (SPMS). We undertook an extensive process to ensure that we found a CRO that could deliver on the unique challenges faced by clinical sites during an SPMS trial, commented Neil K. Warma, President and Chief Executive Officer of Opexa. We are very pleased with the depth of PRA's experience along with their insights into the industry. We are confident that this collaboration with PRA's top-notch clinical management team will provide Opexa superior support to accumulate and report the data from this study in an...

Leading Texas Organizations Combine Their Annual Life Sciences Conferences

noemail@biohouston.org — Mon, 13 Feb 2012 14:00:00 GMT

Houston, TX (February 13, 2012)- Three leading Texas life science organizations today announced that they will combine their annual conferences into a single, large annual event for the life sciences industry in the state, the Texas Life Science Venture Forum. The event hosted by BioHouston, the Rice Alliance for Technology and Entrepreneurship (Rice Alliance) and the Texas Healthcare and BioScience Institute (THBI) will be held on March 8, 2012, at Rice University's BioScience Research Collaborative, 6500 Main Street, Houston, in conjunction with invitation-only events the day before and after the conference. The Texas Life Science Venture Forum is designed to support life sciences entrepreneurs in the state of Texas, connect entrepreneurs with potential investors and strategic partners, provide an educational vehicle for the life science community, and to showcase the vibrancy of the existing life science community in Texas. We expect to showcase 40+ promising...

Quality Assurance Manager

Thu, 10 May 2012 19:20:16 GMT

Title: Quality Assurance Manager Description: GENERAL PURPOSE To support the Company's vision, mission, and values by demonstrating: excellence and competence, collaboration, innovation, respect, commitment to our community, and accountability. The Quality Assurance Manager reports to Senior VP of Operations and Quality Systems and leads management in the development and continuous improvement of the Quality System to include quality control, quality assurance and validation activities and the implementation of quality performance indicators. The QA Manager interfaces with QC, manufacturing and clinical research staff as well as a variety of technical representatives, vendors and consultants to ensure compliance with quality system requirements throughout the organization. DUTIES AND RESPONSIBILITIES Primary duties and responsibilities of this role include the following. Other related duties may be assigned to meet business...

Senior Research Associate

Tue, 17 Apr 2012 17:59:54 GMT

Title: Senior Research Associate Description: Position: Senior Research Associate Department: Research & Development Organizational Relationships: Reports to the Senior Scientist and is responsible for performing a variety of immunological techniques in support of product and process development in a GLP environment. Works cooperatively with other R&D staff to successfully perform overall job duties. Position Overview: Work independently and under minimum supervision to perform various immunological assays in support of immune monitoring programs, and T-cell line generation to advance cellular process development, and Quality Control methods. Provide guidance, support training, and offer constructive feedback to Research Associates. Analyze data and report results according to established policies and procedures. Trouble-shoot under the guidance of the Senior Scientist; monitor programs to...

Quality Control Associate

Tue, 17 Apr 2012 17:58:27 GMT

Title: Quality Control Associate Description: Position: Quality Control Associate Department: Quality Control Organizational Relationships: Reports to the Quality Control Manager and provides valuable support to the Quality Control Analysts. Flexibility required to support the Manufacturing Manager and staff as needed. Works cooperatively with other operational staff to successfully perform overall job duties. Position Overview: Understands, follows and upholds company policies and procedures to ensure GMP/ GLP and OSHA compliance. Accessioning functions, including centralized accessioning of all incoming specimens and accessioning of all samples for Quality Control testing. Maintenance of report files. Maintains the specimen archival inventory system. Distributes and organizes quarantined and released reagents following approved procedures and established inventory...

Manufacturing Support Technician

Tue, 17 Apr 2012 17:56:46 GMT

Title: Manufacturing Support Technician Description: Position: Manufacturing Support Technician Department: Manufacturing Organizational Relationships: Reports to the Manufacturing Manager as well as works under the direction of the Manufacturing Supervisor and provides valuable support to the Manufacturing Cell Therapy Technologists. Flexibility required to support the Quality Control Manager and staff as needed. Works cooperatively with other operational staff to successfully perform overall job duties. Position Overview: Maintain manufacturing batch record files including check in and checkout procedures between quality assurance, manufacturing personnel, and file storage. Maintain inventory of cryopreserved cellular products including storage and documentation of chain of custody. Maintain inventory of consumable materials used within the manufacturing area. Maintain and...

Senior Director, Process Development

Tue, 17 Apr 2012 05:00:00 GMT

Title: Senior Director, Process Development Description: Senior Director, Process Development This position is responsible for all process development programs within the Company. This position will lead both upstream and downstream process science teams to support overall early to late stage clinical/commercial process development within a biotherapeutics manufacturing environment. The Senior Director will oversee all major technology transfer processes for vaccine and other therapeutic manufacturing to and from the Company. Essential Job Functions: • Responsible for developing and overseeing upstream processes • Responsible for developing and overseeing downstream processes • Provides overall leadership in running a cGMP process development laboratory or pilot scale facility • Selects, develops, and evaluates personnel • Interacts with regulatory agencies • Prepares reports and documentation ...

Senior Scientist, Process Development

Tue, 17 Apr 2012 05:00:00 GMT

Title: Senior Scientist, Process Development Description: Senior Scientist, Process Development This position is responsible for overseeing the development of robust and efficient processes for extracting and purifying recombinant proteins expressed in plant tissue or other expression media and scaling them up for production. Essential Job Functions: • Oversees the Operations of the Assay and Process Development Laboratory • Facilitates the Development of Cell Culture Technologies and Purification Strategies • Supervises Junior Staff in Assay and Process Development • Provides Expertise in Protein Chemistry, Analysis, and Purification • Responsible for Team Collaboration and Communication • Prepares Reports and Documentation Marginal Job Functions: • Assists in Documentation Administration Qualifications: Master's Degree in chemistry, life sciences, engineering, or other related...

Manufacturing Supervisor

Mon, 19 Mar 2012 20:21:29 GMT

Title: Manufacturing Supervisor Description: Position: Manufacturing Supervisor, Lonza Houston, Inc. Location: Houston Role Summary: Supervises production processes and manufacturing personnel. Leads the transition of new processes from PD to manufacturing. Reviews and approves Batch Records, Change Controls, Deviations and other manufacturing documentation required for cGMP production operations. Provides training to manufacturing technicians. Coordinates the production schedule and maintains raw material inventory to support. May also perform such cGMP manufacturing tasks as operation of large scale cell culture bioreactors, large scale chromatography and aseptic filling. Responsible for overall cGMP compliance of the department and may represent manufacturing on project teams or during external audits. Primary Role Responsibilities: Responsible for supervising Manufacturing personnel. Responsible for coordinating schedule of production...

Board--Executive Committee--Given

Tue, 07 Feb 2012 15:39:12 GMT

Bruce D. Given, M.D. Chief Operating Officer, Arrowhead Research Corporation Dr. Given currently serves as Chief Operating Officer of Arrowhead Research Corporation. From 2002 to 2007 Dr. Given served as President, Chief Executive Officer and member of the Board of Directors of Encysive Pharmaceuticals. In addition, he has held senior operational roles with Johnson & Johnson as President, International for Ortho Clinical Diagnostics and Group Vice President and Head, Research and Development, Sales and Marketing for Janssen Pharmaceutica(US), as well as various executive and senior management positions at Sandoz Pharma Ltd., Sandoz Research Institute and Schering-Plough Corporation. Before entering the pharmaceutical industry, Dr. Given was on the medical faculty at the University of Chicago. Since February 1, 2010, Dr. Given has served as Chief Executive Officer of Leonardo Biosystems, Inc., a company in which Arrowhead maintains a...

Biotechnology Commercialization Center (BCC)

Tue, 03 Jan 2012 18:42:12 GMT

BioHouston has partnered with UT Health for the expansion of wet laboratory facilities available to life science companies. The Biotechnology Commercialization Center (BCC), which is located at The University of Texas Health Science Center at Houston (UTHealth), is available for the incubation of startup companies. The mission of the center is to help facilitate the next breakthrough in the diagnosis or treatment of disease by providing office, laboratory and conference space, as well as access to UTHealth equipment and core analytical facilities. BioHouston's science laboratory equipment has been relocated to the BCC. The BCC's proximity to other institutions in the Texas Medical Center provides valuable access to information, collaboration and expertise. The BCC consists of over 20,000 sq. ft of laboratory and office space on three adjacent floors. ...

Board: Daniel J. Moore

Fri, 16 Sep 2011 15:07:36 GMT

Daniel J. Moore.
President & Chief Executive Officer
Cyberonics, Inc.

Dan Moore became President and Chief Executive Officer of Cyberonics in May 2007. During the first three years of his tenure, the Company resumed meaningful epilepsy revenue growth and returned to profitability after multiple years of losses. Net sales for fiscal year 2010 were $167.8 million resulting in income from operations of $36.9 million. Under the direction of Mr. Moore and his senior management team, Cyberonics is focused on introducing medical devices and expanding Vagus Nerve Stimulation (VNS) Therapy® franchise for patients suffering from epilepsy.

Cyberonics has approximately 500 employees world-wide, with more than 430 in the U.S. Cyberonics’ stock is traded on the NASDAQ stock exchange under the symbol CYBX.

Mr. Moore joined Cyberonics from Boston Scientific where, since 1989, he held positions in sales, marketing and senior management in the United States and in Europe. In his last position at Boston Scientific, he was President, International Distributor Management. Prior to this, he was President, Inter-Continental, the fourth largest business unit of Boston Scientific with more than 1,000 global employees and revenues exceeding $700 million. Mr. Moore began his career with Procter and Gamble after graduating from Harvard College. He also earned an MBA from Boston University.

In addition to Cyberonics, he serves on the boards of Trivascular, Inc., Medical Device Manufacturers Association (MDMA), BioHouston, Weldon School of Biomedical Engineering at Purdue University, the Epilepsy Foundation of Texas and the National Epilepsy Foundation.

Board: Paul Klotman

Fri, 16 Sep 2011 15:00:40 GMT

Paul Klotman, M.D.
President & CEO
Baylor College of Medicine

Paul Klotman, M.D., assumed the post of President and CEO at Baylor College of Medicine Sept. 1, 2010. Dr. Klotman received his B.S. degree in 1972 from the University of Michigan and his M.D. from Indiana University in 1976. He completed his Medicine and Nephrology training at Duke University Medical Center. He stayed at Duke as a faculty member, rising to the rank of Associate Professor of Medicine before moving to the NIH in 1988 where he became Chief of the Molecular Medicine Section in the Laboratory of Developmental Biology. In 1993, he became Chief of the Viral Pathogenesis Laboratory in the NIDR/NIH. In 1994 he moved to Mt. Sinai School of Medicine as the Irene and Dr. Arthur M. Fishberg Professor of Medicine and the Chief, Division of Nephrology. In 2001, he was selected to be the Chairman of the Samuel Bronfman Department of Medicine. Dr. Klotman is a noted scientist whose work has included both basic and clinical research in molecular virology and AIDS pathogenesis. He has been an active clinician, teacher, and mentor.

CEO Dinner

Fri, 12 Aug 2011 15:48:40 GMT

The leaders of Houston region's growing biotechnology industry know the challenges of running a life science company. The CEO Dinner is an opportunity for these leaders to get to know and network with each other in a informal setting, away from the workplace and in one of Houston's finer establishments. These meetings feature a guest speaker pertinent to the industry and plenty of opportunity for networking and discussion. Open only to Life Science company CEO's, this exclusive dinner allows these executives the opportunity to frankly discuss their industry.

For more information, please contact Elizabeth Hicks at 713.979.9106.

Associate Advisory Board

Tue, 14 Jun 2011 13:36:34 GMT

Meg Boulware - Chair Baker & McKenzie LLP Danguole Altman Vapogenix William Altman CorInnova Bill Arend Oracle Meredith Brown AlphaDev Wendy Burke Linbeck Hoagy Cannon Vaughn Construction David Carter Capital Royalty Michael Coleman Ingeneron John Farrell FKP Architects Bruce Given ICON plc Chyau Liang Osha Laing LLP ...

BioHouston Breakfast Forum

Mon, 23 May 2011 21:53:44 GMT

Tuesday, June 21st, 2011 7:30 AM- 9:00 AM James T. Willerson, MD, President, Texas Heart Institute James T. Willerson, MD, is the president and medical director, director of Cardiology Research, and co-director of the Cullen Cardiovascular Research Laboratories at Texas Heart Institute (THI). In 1989, he was named the Edward Randall III Chair, Department of Internal Medicine at The University of Texas Medical School at Houston. He was president of The University of Texas Health Science Center at Houston from 2001 to 2008 and was named the Alkek-Williams Distinguished Professor there at the same time. Dr. Willerson was appointed president-elect of THI in 2004 and became president and medical director in 2008. He is also an adjunct professor of Medicine at Baylor College of Medicine and at The University of Texas MD Anderson Cancer Center. He is the former chief of Cardiology at St. Luke's Episcopal Hospital and the former chief of...

8th Annual Chili Cook-Off

Tue, 03 May 2011 19:50:25 GMT

Put a little SPICE in your life...; 8th Annual BioHouston Chili Cook-Off April 1st, 2011 View Some Pictures of The Event! Chili Cook-Off Video! Watch The Fun In Action! 8th Annual BioHouston Chili Cook-Off Winners: Best of Show: CitareTx Investment Partners Hottest Chili: JE Dunn Construction Best Traditional Chili: CitareTx Investment Partners Best Non-Traditional Chili: PhiloWilke Partnership / Tribble & Stephens Construction Hula-Hoop Champ: Jiefeng Chen, inVentiv Clinical Solutions Jalepeno Eating Champ: Kevin Hlavinka, Cyberonics Limbo Champ: Michelle Albright, Lexicon Pharmaceuticals Best Dessed Team: Texas Heart Institute Most Unique Team: Texas Heart Institute Best Themed Team: Texas Heart Institute ...

Michael E. Debakey Life Science Award

Tue, 19 Apr 2011 14:44:17 GMT

The Michael E. DeBakey Memorial Life Science Award is given each year to the undiscovered life science company with the highest potential to commercialize an important product at the annual Texas Life Science Conference. The first DeBakey Award was given to ThromboVision, Inc. in 2006. Dr. DeBakey's rich history in Houston and the Texas Medical Center, along with his pioneering spirit, truly embodied the qualities that we are seeking in future recipients of this award. Some of Dr. DeBakey's most renowned contributions included the concept of the Mobile Army Surgical Hospitals (MASH units), performing the first successful artificial heart transplant, playing an instrumental role in the development of the Ventricular Assist Device (VAD) and being the first to successfully implant the device into a human. Additionally, he served as consultant to almost every U.S. President in this century and received many prestigious awards, including the Presidential Medal of Freedom with...

2011 Chili Cook-Off Team Information

Sun, 06 Mar 2011 22:45:57 GMT

Team Registration So, you think you've got an award winning chili recipe? Well put it to the test by entering a team in the 8th Annual BioHouston Chili Cook-Off! Chili Cook-Off Team Rules: 1. Each team will be allotted a 12'x12' space. As space is limited, you must ensure that your tents and ropes will fit inside this area. 2. Chili may be cooked on-site or prepared ahead to ensure chili is ready for judging. 3. Propane burners are allowed for cooking - no gas powered generators or barbecue rigs allowed. Please be sure your cooking equipment is in safe working condition. 4. No power outlets will be available to any teams. Please make sure you have the appropriate equipment should you need power. 5. Teams are responsible for supplying all their equipment needed - tables, chairs, tent, cooking equipment, serving utensils, etc. 6. Teams need to prepare enough chili to allow for sampling by all judges. Extra...

2010 Life Science CEO Summit Feedback

noemail@biohouston.org — Thu, 04 Mar 2010 23:00:00 GMT

Objectives: To help us make the CEO Summit more relevant to your business, we ask that you complete this short survey to let us know your thoughts.

Release Date: 4-Mar-10 5:00 PM
Expiration Date: 2-Jun-10 5:00 PM

Please fill in the survey. You responses will be forwarded to BioHouston for tabulation and review.

Texas Life Science Conference -- Emerging Company Survey

noemail@biohouston.org — Thu, 28 Aug 2008 20:00:00 GMT

Objectives: At the 2008 Texas Life Science Conference, your company has the opportunity to benefit from several add-on events not available to the regular attendee. Please take this quick and easy survey to better help us serve you.

Release Date: 28-Aug-08 3:00 PM
Expiration Date: 26-Nov-08 3:00 PM
Please fill out the following survey and someone from the BioHouston staff will be in touch with you shortly regarding registration materials and payment options.

Strategic Planning Initial Test

noemail@biohouston.org — Wed, 16 Jan 2008 16:00:00 GMT

Objectives: BioHouston will use this data to prepare for the future.

Release Date: 16-Jan-08 10:00 AM
Expiration Date: 15-Apr-08 10:00 AM

DSC01257

Thu, 17 May 2012 14:57:50 GMT

Our Best of Show Chili Winners, CitareTx Investment Partners!

DSC01249

Thu, 17 May 2012 14:57:50 GMT